Statistics for Kura Oncology (id:7886 KURA)
Valuation metrics
Market cap
1.24B
Enterprise value
799.33M
Trailing P/E (ttm)
-5.19
Forward P/E
-5.96
PEG ratio
-5.96
Price/Sales (ttm)
Price/Book (mrq)
2.92
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.69
Overview
Shares outstanding
77.76M
Float
50.22M
Shares short
10.80M
% Held by insiders
0.01%
% Held by institutions
1.08%
Average volume (10 days)
959.09K
Average volume (90 days)
Price summary
52-Week low
9.06
52-Week high
24.17
52-Week change
14.26%
Beta
0.86
50-Day moving average
18.50
200-Day moving average
20.10
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-28.54%
Return on equity
-46.28%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-216,644,000.00
Net income to common (ttm)
-197,552,000.00
Diluted EPS (ttm)
-2.35
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
455.30M
Total cash per share (mrq)
5.86
Total debt (mrq)
16.63M
Total Debt/Equity (mrq)
3.92
Current ratio (mrq)
1.15K%
Book value per share (mrq)
5.45
Cash flow
Cash flow statement
-169,122,000.00
Levered free cash flow (LFCF)
-93,215,000.00